Ainnocence unveils AI for antibody affinity and GPCR design via SentinusAI®. Mapping 59 GPCR families, 175 targets, and 444 indications for advanced drug design SAN FRANCISCO , CALIFORNIA, UNITED ...

Pipeline led by a new proprietary oral small molecule GLP-1 agonist and six additional innovative programs targeting the GIP, ...

This review explores how generative AI, through models like VAEs, GANs, transformers, and diffusion networks is ...

October 15, 2008 (Vol. 28, No. 18) Understanding Allosteric Modulation and Functional Selectivity Are Key Priorities Bryan Roth, M.D., Ph.D., director of the National Institute of Mental Health ...

These multifaceted proteins will be the subject of “GPCR Structure, Function and Drug Discovery,” a Global Technology Community conference scheduled to take place May 22–23 in Boston.

In conclusion, the study suggests that machine learning-predicted structures, such as those generated by AlphaFold, can effectively identify GPCR ligands, accelerating drug discovery for novel ...

Lead Structure drug candidate GSBR-1290 is currently in mid-stage clinical development for type 2 diabetes and obesity.

Structure Therapeutics (NASDAQ:GPCR) stock is surging today, up 60% after the biotech company reported promising results of its mid-stage trials for its weight loss pills. Indeed, after 12 weeks ...